SEARCH

Entries in Actemra (1)

Saturday
Apr162011

Drug for Juvenile Arthritis Gets 'OK' from the FDA

Jupiterimages/Thinkstock(WASHINGTON) -- The Food and Drug Administration has granted wider use of a drug for juvenile arthritis. Actemra was approved to treat children aged two years or older with active systemic juvenile idiopathic arthritis (SJIA), a rare illness for children.

The drug, made by Roche Holding AG, was approved last year as a treatment for adult arthritis patients for who don't receive an adequate response from other medications.

According to the FDA, SJIA is a potentially life-threatening illness that causes inflammation throughout the entire body.

Copyright 2011 ABC News Radio








ABC News Radio